Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We are delighted to announce that Professor KJ Patel has been appointed as the new Director of the MRC Weatherall Institute of Molecular Medicine and the MRC Molecular Haematology Unit at the University of Oxford.

Professor KJ Patel FRS FMedSci will start full-time as Director of the MRC Weatherall Institute of Molecular Medicine (MRC WIMM) and the MRC Molecular Haematology Unit (MRC MHU) from 1st June 2020. Between 1st April to 31st May, Professor Patel will be managing these two roles on a part-time basis, whilst transitioning his research programme from the MRC Laboratory of Molecular Biology in Cambridge (MRC LMB), where he is currently based.

Professor Hugh Watkins, Head of the Radcliffe Department of Medicine, said “I am delighted to welcome KJ to the department and am excited about his vision for the MRC MHU and the MRC WIMM. KJ is a scientist of the highest distinction whose own work epitomises how fundamental molecular insights drive important medical advances.”

Professor Patel trained as a physician in London, specialising in gastroenterology. He completed a PhD with the late Michael Neuberger FRS at the MRC LMB in B cell immunology, and later returned to the MRC LMB as an MRC Clinician Scientist working with Professor Ashok Venkitaraman FMedSci. There, he and others discovered that BRCA2 is a DNA repair factor.

“I am delighted to be appointed to this position” said Professor Patel “When preparing for an exam as a medical student, I was given a book that I read overnight and changed the course of my career. The book was ‘Genetics and Clinical Medicine’ by David Weatherall. So it seems fitting that I find myself coming to the MRC WIMM at this stage of my career, considering the impact that it had on me at the start of it.”

Professor Patel is also a Fellow of the Royal Society and the Academy of Medical Sciences, and a member of EMBO. The Patel group currently investigates the genetic and physiological foundations of DNA crosslink repair, explaining why this is essential in haematopoiesis.

 

Similar stories

Anjali Kusumbe receives the RMS Life Sciences Medal

The Royal Microscopical Society awards celebrate the best in microscopy, recognising those making a special contribution to microscopy, cytometry and imaging.

Wellcome Trust funding success for Jim Hughes and James Davies

£3.6 million in funding awarded by the Wellcome Trust to combine cutting-edge 3D genome technologies with machine learning approaches to decipher the role of the non-coding genome in disease.

Study of T-cell receptor activation leads to surprising discovery

A study from Davis Group is the first to describe the structure of the T-cell receptor when bound to an activating ligand. The findings shed light on an important trigger in the immune system, and suggest a completely new process by which cell receptors can be activated.

Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m

Co-founded by Prof. Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.

Seven research groups secure LEAF Sustainability Awards

The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.